1. Medtech Insight
  2. >>Geography
  3. >>Europe

Council Of EU Develops European Health Data Space Mandate To Kick Off Trilogue Negotiations

 
• By Natasha Barrow

The Council of the EU has issued a mandate that addresses concerns with patient data autonomy and data localization within the EHDS regulation proposal. It introduces the concepts of data space steering groups and a member state biennial activity report.

EDHS
• Source: Shutterstock

The Council of the EU has agreed on a mandate to begin negotiations with the European Parliament on the European Health Data Space regulation proposal. Trilogues, including the European Commission, are expected to start this month, with parliament aiming to finalize its position by 13 December before a final review by the Council of the EU.

The mandate, which was announced on 6 December, addresses concerns raised by last week’s Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) meeting, including patient data autonomy and data storage

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

More from Geography

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

Disparities — Including Financials Shortcomings — Remain In Women’s Health, Execs Say

 
• By Brian Bossetta

FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.